Status:
UNKNOWN
Intensive Molecular and Electropathological Characterization of Patients Undergoing Atrial Fibrillation Ablation
Lead Sponsor:
Maastricht University
Collaborating Sponsors:
Maastricht University Medical Center
Radboud University Medical Center
Conditions:
Atrial Fibrillation
Atrial Fibrillation Paroxysmal
Eligibility:
All Genders
18+ years
Brief Summary
Rationale: Although there are several individual factors which are known to influence the chances of successful atrial fibrillation (AF) ablation, it remains a challenge to identify patients at risk ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- 18 years of age or older;
- Documented atrial fibrillation;
- Scheduled for AF ablation or redo AF ablation;
- Able and willing to provide written informed consent.
- Exclusion criteria
- Serious patient condition before ablation;
- Physically or mentally unable to provide written informed consent.
Exclusion
Key Trial Info
Start Date :
March 5 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2024
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04342312
Start Date
March 5 2020
End Date
May 1 2024
Last Update
May 5 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Radboudumc
Nijmegen, Gelderland, Netherlands, 6525 GA Nijmegen
2
Maastricht UMC+
Maastricht, Limburg, Netherlands, 6229 HX